Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Jia-Yi Wu,1,2,* Zhen-Yu Yin,3,* Yan-Nan Bai,1,2 Yu-Feng Chen,4 Song-Qiang Zhou,1,2 Shuang-Jia Wang,5 Jian-Yin Zhou,6 Yi-Nan Li,2 Fu-Nan Qiu,1,2 Bin Li,5 Mao-Lin Yan1,2 1Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, 350001, People’s Republic o...

Full description

Bibliographic Details
Main Authors: Wu JY, Yin ZY, Bai YN, Chen YF, Zhou SQ, Wang SJ, Zhou JY, Li YN, Qiu FN, Li B, Yan ML
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
unresectable hepatocellular carcinoma
tumor response
adverse events
combination therapy
monotherapy
Online Access:https://www.dovepress.com/lenvatinib-combined-with-anti-pd-1-antibodies-plus-transcatheter-arter-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/lenvatinib-combined-with-anti-pd-1-antibodies-plus-transcatheter-arter-peer-reviewed-fulltext-article-JHC

Similar Items